Latest intangible assets for PBIGF: $900K.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Paradigm Biopharmaceuticals Limited (PBIGF) currently reports a intangible assets of $900K as of June 2026. That compares with $410K in the prior-year period — up 118.1% year over year. Use the charts on this page to explore Paradigm Biopharmaceuticals Limited's intangible assets history and peer comparisons.
Paradigm Biopharmaceuticals Limited's intangible assets increased from $410K to $900K — a 118.1% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Paradigm Biopharmaceuticals Limited reported $900K in intangible assets as of June 2026. That compares with $410K in the prior-year period — up 118.1% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current intangible assets of $900K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Paradigm Biopharmaceuticals Limited, and consider following PBIGF for alerts when major investors trade the stock.
Paradigm Biopharmaceuticals Limited is classified in the Healthcare sector. On intangible assets, it currently shows $900K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing PBIGF with unrelated industries.